Nara Tae
Overview
Explore the profile of Nara Tae including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho J, Tae N, Song Y, Kim C, Lee S, Ahn J, et al.
Cancer Immunol Immunother
. 2024 Aug;
73(10):196.
PMID: 39105814
Anti-cluster of differentiation (CD) 3 × α programmed death-ligand 1 (PD-L1) bispecific T-cell engager (BsTE)-bound T-cells (BsTE:T) are a promising new cancer treatment agent. However, the mechanisms of action of...
2.
Lee K, Choi D, Tae N, Song H, Kang Y, Lee M, et al.
Cell Rep Med
. 2024 May;
5(5):101567.
PMID: 38744277
Bispecific T cell engagers (TCEs) show promising clinical efficacy in blood tumors, but their application to solid tumors remains challenging. Here, we show that Fc-fused IL-7 (rhIL-7-hyFc) changes the intratumoral...
3.
Cho J, Tae N, Ahn J, Chang S, Ko H, Kim D
Biomol Ther (Seoul)
. 2024 Apr;
32(3):400-401.
PMID: 38684583
No abstract available.
4.
Cho J, Tae N, Ahn J, Chang S, Ko H, Kim D
Biomol Ther (Seoul)
. 2022 May;
30(5):418-426.
PMID: 35577765
Chimeric antigen receptor T (CAR-T) cell therapy is one of the promising anticancer treatments. It shows a high overall response rate with complete response to blood cancer. However, there is...
5.
Moon D, Tae N, Park Y, Lee S, Kim D
Immune Netw
. 2022 Mar;
22(1):e4.
PMID: 35291652
In the era of immunotherapeutic control of cancers, many advances in biotechnology, especially in Ab engineering, have provided multiple new candidates as therapeutic immuno-oncology modalities. Bispecific Abs (BsAbs) that recognize...
6.
Choi J, Kim M, Tae N, Wi T, Kim S, Lee E, et al.
Viruses
. 2020 Jul;
12(6).
PMID: 32630442
The therapeutic functionality of the antibodies from phage display is verified after an initial screening. Several immunological assays such as ELISA, flow cytometry, the western blot, and surface plasmon resonance...
7.
Kim M, Choi J, Tae N, Wi T, Kim K, Kim D, et al.
Int J Mol Sci
. 2020 May;
21(9).
PMID: 32380650
Mucin1 (MUC1) is aberrantly glycosylated and overexpressed in various cancers, and it plays a crucial role in cancerogenesis. MUC1 is a type I membranous protein composed of α and β...
8.
Tae N, Manh Hung T, Kim O, Kim N, Lee S, Na S, et al.
Oncotarget
. 2017 Dec;
8(54):92346-92358.
PMID: 29190920
Angiogenesis is one of the hallmarks of cancer, playing an essential role in tumor growth, invasion, and metastasis. 3β-Acetyl-nor-erythrophlamide (3-ANE), a cassaine diterpene alkaloid compound from , exerts various pharmacological...
9.
Tae N, Lee S, Kim O, Park J, Na S, Lee J
Oncotarget
. 2017 Apr;
8(24):38886-38901.
PMID: 28418925
Syntenin, a tandem PDZ-domain-containing scaffold protein, is involved in the regulation of diverse biological functions, including protein trafficking, exosome biogenesis, and cancer metastasis. Here, we present the first study to...
10.
Choi S, Nguyen V, Tae N, Lee S, Ryoo S, Min B, et al.
Toxicol Appl Pharmacol
. 2014 Sep;
280(3):434-42.
PMID: 25239868
Ganoderma lucidum is a popular medicinal mushroom used in traditional medicine for preventing or treating a variety of diseases. In the present study, we investigated the anti-inflammatory and heme oxygenase...